| Factor | Category/increment | AMD severity score (n = 1143) | Presence of CNV (n = 139) | Presence of CGA (n = 21) | B | 95% CI | value | B | 95% CI | value | B | 95% CI | value |
| Univariate |
| Age | 1 year | 0.102 | 0.049, 0.155 | <0.001 | 0.052 | 0.017, 0.087 | 0.003 | −0.023 | −0.125, 0.078 | 0.651 | Sex | Female vs. male | −0.068 | −0.376, 0.240 | 0.663 | −0.018 | −0.401, 0.364 | 0.926 | −0.267 | −1.134, 0.601 | 0.547 | Smoking status | Never | Ref | | | Ref | | | Ref | | | Former | 0.365 | −0.175, 0.905 | 0.185 | −0.064 | −0.419, 0.291 | 0.723 | − | −1.041, 0.760 | 0.759 | Current | 1.071 | 0.189, 1.953 | 0.017 | 0.281 | −0.261, 0.822 | 0.310 | −0.018 | −1.535, 1.500 | 0.982 | Cilioretinal artery | Present vs. absent | −1.009 | −1.546, −0.473 | <0.001 | −0.721 | −1.257, −0.186 | 0.008 | −0.081 | −1.169, 1.006 | 0.883 | CRAE | 1 mm | −0.008 | −0.022, 0.006 | 0.240 | −0.001 | −0.011, 0.009 | 0.821 | −0.026 | −0.045, −0.007 | 0.007 | CRVE | 1 mm | 0.005 | −0.010, 0.020 | 0.500 | 0.005 | −0.005, 0.015 | 0.343 | −0.022 | −0.051, 0.007 | 0.132 | AVR | — | −4.853 | −9.148, 0.559 | 0.027 | −1.940 | −5.381, 1.500 | 0.269 | −5.794 | −11.48, −0.112 | 0.046 |
| Multivariate |
| Age | 1 year | 0.104 | 0.053, 0.155 | <0.001 | 0.052 | 0.017, 0.087 | 0.003 | | | | Smoking status | Never | Ref | | | | | | | | | Former | 0.299 | −0.242, 0.841 | 0.278 | | | | | | | Current | 1.109 | 0.246, 1.971 | 0.012 | | | | | | | Cilioretinal artery | Present vs. absent | −0.909 | −1.439, −0.378 | 0.001 | −0.720 | −1.256, −0.183 | 0.009 | | | | AVR | | −4.592 | −8.842, −0.342 | 0.034 | | | | | | |
|
|
AMD, age-related macular degeneration; CNV, choroidal neovascularization; CGA, central geographic atrophy; B, beta coefficient; CI, confidence interval; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; AVR, arteriole-to-venule ratio.
|